CorMedix Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for CRMD, updated each market day.
CRMD AI Sentiment
AI sees no strong directional signal for CorMedix Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Sector
Exchange
Market Cap
$581,810,907
Cap Tier
Employees
191
Headquarters
PARSIPPANY, NJ
Listed Since
May 13, 2010
Website
CRMD Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CRMD Volatility
CorMedix Inc. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
